These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 4068219)

  • 61. [Experience with cefaclor in the treatment of ear, nose and throat infections. Indications for cefaclor therapy (author's transl)].
    Federspil P; Bach R; Weich C; Wilhelm HJ; Tiesler E; Schätzle W
    Infection; 1979; 7 Suppl 6():609-14. PubMed ID: 551089
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The efficacy and safety of cefaclor in respiratory infections amongst Pakistani children.
    Najam Y; Walla FL; Iqbal A; Khan MK; Aqil S; Sharif MW; Masood T; Gaba I; Malik BA; Hassan M; Malik S; Hassan S; Bukhari KA; Khawar N; Tarar MA
    J Pak Med Assoc; 2000 Sep; 50(9):289-93. PubMed ID: 11043017
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Laboratory and clinical studies on norfloxacin in the pediatric field].
    Toyonaga Y; Koizumi M; Imai H; Sakaguchi N; Sugita M; Fukushima Y; Yamasaki M
    Jpn J Antibiot; 1990 May; 43(5):808-25. PubMed ID: 2391752
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Experimental and clinical evaluation of cefotetan in pediatrics].
    Iwai N; Sasaki A; Taneda Y; Mizoguchi F; Nakamura H
    Jpn J Antibiot; 1983 Jun; 36(6):1279-94. PubMed ID: 6581333
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Clinical studies on cefadroxil in pediatrics (author's transl)].
    Terashima I; Nakamura A; Okimoto Y; Kurosaki T; Uehara S
    Jpn J Antibiot; 1981 Jan; 34(1):25-32. PubMed ID: 7017196
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cefaclor and cefadroxil: a commentary on their properties and possible indications for use in pediatrics.
    Ginsburg CM; McCracken GH
    J Pediatr; 1980 Feb; 96(2):340-2. PubMed ID: 7351610
    [No Abstract]   [Full Text] [Related]  

  • 67. [Laboratory and clinical studies on cefadroxil in the field of pediatrics (author's transl)].
    Iwai N; Sasaki A; Miyazu M; Osuga T
    Jpn J Antibiot; 1981 Jan; 34(1):77-94. PubMed ID: 7241809
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Double-blind comparative trial of cefroxadine and cephalexin in the treatment of acute suppurative otitis media and acute exacerbation of chronic suppurative otitis media].
    Baba S; Murai K; Kinoshita H; Kawai T; Koyama K; Tsukiyama M; Maruo T; Wada K; Inagaki M; Matsushita T
    Jpn J Antibiot; 1983 Sep; 36(9):2595-634. PubMed ID: 6361325
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Pharmacokinetic, bacteriological and clinical studies on cefpodoxime proxetil in the field of pediatrics].
    Akita H; Sato Y; Iwata S; Sunakawa K
    Jpn J Antibiot; 1989 Jul; 42(7):1547-60. PubMed ID: 2810729
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Bacteriological, pharmacokinetic and clinical studies on cefteram pivoxil in the pediatric field].
    Toyonaga Y; Imai H; Sugita M; Fukushima Y; Yamazaki M; Hori M
    Jpn J Antibiot; 1989 Aug; 42(8):1799-814. PubMed ID: 2810743
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Efficacy evaluation of aztreonam for suppurative otitis media].
    Baba S; Kinoshita H; Mori Y; Suzuki K; Furuuchi C; Baba K; Tanigaito Y; Nagae D; Kawai T; Maruo T
    Jpn J Antibiot; 1986 Jan; 39(1):159-76. PubMed ID: 3517406
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Clinical and bacteriological studies on panipenem/betamipron in pediatrics. Kanagawa Research Group for Infectious Diseases of Children].
    Kato T; Goshima T; Akita H; Mizuhara H; Koitabashi Y; Minohara Y; Sugaya N; Ozaki A; Miura M; Takakura I; Oh Y; Shikada M; Shibawaka T; Hara M; Banba M; Azakami S; Mori N; Arimoto Y; Yokota T; Shimizu S; Koori T; Shiro H; Jozaki K; Kasai N; Kaku H
    Jpn J Antibiot; 1998 Apr; 51(4):286-97. PubMed ID: 9644602
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Bacteriological, pharmacokinetic and clinical evaluation of azithromycin in the pediatric field].
    Akita H; Sato Y; Kusumoto Y; Iwata S; Takeuchi Y; Aoyama T; Yokota T; Sunakawa K
    Jpn J Antibiot; 1996 Oct; 49(10):899-916. PubMed ID: 8986553
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Treatment of acute bacterial pneumopathies with cefaclor].
    Pasternak J; Levi GC; Nakasu EV; Nitrini DR; Amato Neto V
    Rev Inst Med Trop Sao Paulo; 1980; 22(6):303-5. PubMed ID: 7244517
    [No Abstract]   [Full Text] [Related]  

  • 75. Cefaclor in the treatment of susceptible infections in infants and children.
    Rodriguez WJ; Ross S; Schwartz R; Goldenberg R; Khan W
    Postgrad Med J; 1979; 55 Suppl 4():35-8. PubMed ID: 548941
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Clinical studies with cefmenoxime in the otorhinolaryngeal field (author's transl)].
    Takeda T; Kajiwara M; Saito R; Masuda Y
    Jpn J Antibiot; 1982 Jan; 35(1):202-5. PubMed ID: 6279910
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Clinical studies on T-2588 in the field of otorhinolaryngology].
    Kawasaki Y; Sakamoto Y; Ogawa S; Tsuchihashi N
    Jpn J Antibiot; 1986 Oct; 39(10):2710-5. PubMed ID: 3806956
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Cefaclor dosage change with renal dysfunction].
    Usuda Y; Sekine O
    Jpn J Antibiot; 1985 Apr; 38(4):1141-6. PubMed ID: 4032725
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Clinical experience with sustained release cephalexin (S-6437) in pediatrics (author's transl)].
    Hori M; Okamoto K; Kohno S
    Jpn J Antibiot; 1978 Feb; 31(2):59-71. PubMed ID: 642208
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Cefaclor and trimethoprim-sulfamethoxazole for recurrent otitis media].
    Fliss DM; Krauss M; Gorodischer R; Bearman J; Lieberman A
    Harefuah; 1989 Dec; 117(11):361-3. PubMed ID: 2695415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.